Development and evaluation of a BK polyomavirus serotyping assay using Luminex technology-Reference-Cited by-同舟云学术

Development and evaluation of a BK polyomavirus serotyping assay using Luminex technology

Published:2019-01 Issue: Volume:110 Page:22-28
ISSN:1386-6532
Container-title:Journal of Clinical Virology
language:en
Short-container-title:Journal of Clinical Virology

Author:

Wunderink Herman F.^ORCID,de Brouwer Caroline S.,van der Meijden Els,Pastrana Diana V.,Kroes Aloysius C.M.,Buck Christopher B.^ORCID,Feltkamp Mariet C.W.^ORCID

Funder

Dutch Kidney Foundation

National Institutes of Health Intramural Research Program (USA)

Publisher

Elsevier BV

Subject

Infectious Diseases,Virology

Reference49 articles.

1. BK polyomavirus: clinical aspects, immune regulation, and emerging therapies;Ambalathingal;Clin. Microbiol. Rev.,2017

2. Risk factors for BK virus infection in the era of therapeutic drug monitoring;Borni-Duval;Transplantation,2013

3. Polyomavirus-associated nephropathy in renal transplantation: critical issues of screening and management;Hirsch;Adv. Exp. Med. Biol.,2006

4. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients;Hirsch;N. Engl. J. Med.,2002

5. Risk factors for BK virus infection and BK virus-associated nephropathy under the impact of intensive monitoring and pre-emptive immunosuppression reduction;Huang;Transplant. Proc.,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutralizing Antibodies Targeting BK Polyomavirus;Journal of the American Society of Nephrology;2024-07-09

2. Concurrent JCPyV-DNAemia Is Correlated With Poor Graft Outcome in Kidney Transplant Recipients with Polyomavirus-associated Nephropathy;Transplantation;2024-03-19

3. The role of the DE and EF loop of BKPyV VP1 in the serological cross-reactivity between subtypes;Virus Research;2023-01

4. Pretransplantation seroreactivity in kidney donors and recipients as a predictive factor for posttransplant BKPyV-DNAemia;Frontiers in Immunology;2022-07-25

5. Pretransplant BK Virus-Specific T-Cell-Mediated Immunity and Serotype Specific Antibodies May Have Utility in Identifying Patients at Risk of BK Virus-Associated Haemorrhagic Cystitis after Allogeneic HSCT;Vaccines;2021-10-22